B of A Securities Maintains Buy on Insmed, Maintains $83 Price Target
Portfolio Pulse from Benzinga Newsdesk
B of A Securities analyst Jason Zemansky maintains a Buy rating on Insmed (NASDAQ:INSM) with a price target of $83.
July 05, 2024 | 3:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
B of A Securities analyst Jason Zemansky maintains a Buy rating on Insmed (NASDAQ:INSM) with a price target of $83.
The reaffirmation of a Buy rating and a high price target of $83 by a reputable analyst from B of A Securities is likely to positively influence investor sentiment and drive short-term price appreciation for Insmed.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100